Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/22/2025

Metamizol Administration in Perioperative Setting

Dosage and Administration

  • The American College of Physicians recommends administering metamizol at 2.5 mg/kg/hour after a loading dose of 10-15 mg/kg IV in the perioperative setting, with strict limitation to short-term hospital use (maximum 2-5 days) due to the risk of agranulocitosis 1
  • A loading dose of 10-15 mg/kg IV is fundamental to rapidly achieve therapeutic levels, and this dose is typically administered intraoperatively or in the immediate postoperative period 1, 2
  • The infusion rate of 2.5 mg/kg/hour maintains stable analgesic levels without peaks or troughs 1, 2, 3

Considerations in Renal Insufficiency

  • In patients with moderate to severe renal insufficiency (eGFR <30 mL/min/1.73 m²), the dose should be reduced by 25-50% and closely monitored 1
  • Metamizol is contraindicated in patients with severe renal insufficiency or end-stage renal disease, and alternative analgesics such as fentanyl or methadone should be prioritized 1

Special Populations

  • In elderly patients, paracetamol should be prioritized as first-line therapy, and metamizol should be reserved for when paracetamol is ineffective 1
  • In pediatric patients, the same dosages as adults can be used, with a loading dose of 10-15 mg/kg IV followed by an infusion rate of 2.5 mg/kg/hour 1

Multimodal Analgesia

  • A recommended scheme for optimizing pain control includes paracetamol as the base analgesic, metamizol as an adjuvant, and opioids as rescue medication only for breakthrough pain 1, 2
  • The combination of metamizol with paracetamol and/or NSAIDs significantly reduces the need for opioid rescue 1, 2

Contraindications and Warnings

  • Metamizol is contraindicated in patients with a history of metamizol-induced agranulocytosis, and its use should be strictly limited to short-term hospital settings (maximum 2-5 days) due to the risk of agranulocitosis 1, 3, 2
  • The American Society of Anesthesiologists recommends careful consideration of the risks and benefits of metamizol use in patients with renal insufficiency or other comorbidities 4, 5